SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Combimatrix (CBMX)
An SI Board Since December 2002
Posts SubjectMarks Bans Symbol
237 9 0 CBMX
Emcee:  Paul Lee Type:  Unmoderated
Introduction Market Data Compact
CombiMatrix stock is intended to reflect the performance of Acacia Research's subsidiary, CombiMatrix Corporation. The Acacia Research -- CombiMatrix stock is a class of common stock of Acacia Research and is not a separately issued stock.

The CombiMatrix group, consisting of its wholly-owned subsidiary CombiMatrix Corporation, is developing a platform technology that has a wide range of applications, from DNA synthesis/diagnostics to immunochemical detection. The platform allows the company to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The company is designing its products principally to be responsive to the needs of pharmaceutical, biotechnology, and academic researchers in analyzing raw genomic data in the discovery and development of pharmaceutical products. Information about Acacia Research Corporation is available at www.acaciaresearch.com. Information about CombiMatrix Corporation is available at www.combimatrix.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
237biotuesdays.com CombiMatrix prenatal, pediatric strategic shift paying off Paul Lee-4/22/2014
236 CombiMatrix Skyrockets After Important Medical Publication CombiMatrix SkyroPaul Lee-12/11/2012
235 NIH Studies in New England Journal of Medicine Favor Chromosomal Microarray AnPaul Lee-12/7/2012
234 Author of Nationwide, NIH-Sponsored Study Endorses Microarray Testing as PrePaul Lee-2/13/2012
233CombiMatrix Partners With Clarient to Commercialize CombiMatrix Genomic Profile Paul Lee-4/11/2011
232CBMX - announced today that it has appointed Daniel R. Forche as Senior Vice PrPaul Lee-10/20/2010
231This didn't work out very well, Kumar was doing a better job? I was thinkiJeff Jordan-8/16/2010
230Aug. 16, 2010 (GLOBE NEWSWIRE) operational updates on its strategic restructurinPaul Lee-8/16/2010
229Definitely an inflection point finance.yahoo.com biz.yahoo.com The plan seemsJeff Jordan-4/19/2010
228Mark McGowan Joins CombiMatrix Board of Directors Companies:Combimatrix CorporaPaul Lee-1/25/2010
227CombiMatrix Launches New ElectraSense MicroArray Reader The Smallest, Most EconoPaul Lee-12/16/2009
226BAMC to Use CombiMatrix Influenza Array to Study Genetic Drift of H1N1 Swine FluPaul Lee-10/13/2009
225On September 30, 2009, CombiMatrix Corporation (“CombiMatrix” or the “Company”) Paul Lee-10/5/2009
224CombiMatrix Corporation Engages Robert W. Baird as Financial and Strategic AdvisPaul Lee-9/16/2009
223CombiMatrix Receives New $1.5 Million U.S. Air Force Contract * Press ReleaPaul Lee-9/14/2009
222CombiMatrix Provides Update on Progress of Its Lawsuit With National Union and $Paul Lee-6/22/2009
221CombiMatrix Publishes Clinical Study of Its HerScan(tm) Breast Cancer Test ----Paul Lee-6/3/2009
220MUKILTEO, Wash., Jun 1, 2009 (GlobeNewswire via COMTEX News Network) -- CombiMaPaul Lee-6/1/2009
219CombiMatrix Updates Influenza-Detection System For Swine Flu * On WednesdayPaul Lee-4/29/2009
218Health Agency Verifies Performance of CombiMatrix's Influenza-Detection TechPaul Lee-3/30/2009
217seekingalpha.com Mike Havrilla CombiMatrix (CBMX) is an ETF Innovators EmergingPaul Lee-3/13/2009
216CombiMatrix Receives New Contract From NASA , Wash., March 12, 2009 (GLOBE NEWSWPaul Lee-3/12/2009
215CombiMatrix Announces Positive Preliminary Data on Non-Invasive, Cancer ScreeninPaul Lee-2/26/2009
214Leuchemix Provides Update On Cancer Trial Wednesday January 28, 6:00 am ET MUKPaul Lee-1/28/2009
213Lenetix to Co-Market Combimatrix Molecular Diagnostics' Suite of DevelopmentPaul Lee-1/26/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News